| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000039061 |
| Receipt No. | R000044419 |
| Scientific Title | Technical feasibility and safety of Underwater endoscopic mucosal resection versus Cold snare polypectomy for superficial non-ampullary Duodenal epithelial tumor; A randomized control trials. |
| Date of disclosure of the study information | 2020/01/06 |
| Last modified on | 2020/07/09 (Ver. 3) |
| Basic information | ||
| Public title | Technical feasibility and safety of Underwater endoscopic mucosal resection versus Cold snare polypectomy for superficial non-ampullary Duodenal epithelial tumor; A randomized control trials. | |
| Acronym | DUC study | |
| Scientific Title | Technical feasibility and safety of Underwater endoscopic mucosal resection versus Cold snare polypectomy for superficial non-ampullary Duodenal epithelial tumor; A randomized control trials. | |
| Scientific Title:Acronym | DUC study | |
| Region |
|
|
| Condition | |||
| Condition | Superficial non-ampullary duodenal epithelial tumor | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To conduct a comparative study on the efficacy and safety of underwater endoscopic mucosal resection (UEMR) and cold snare polypectomy (CSP) for duodenal non-papillary epithelial tumors of 12 mm or less. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Primary endpoint is the percentage of complete pathological resection (negative horizontal and vertical resection margins and proportion of resected specimens with submucosa). |
| Key secondary outcomes | Secondary endpoints include en bloc resection rate, R0 resection rate, resected lesion diameter, treatment time, pathological evaluation of resected lesions (resection thickness, resection distance, presence or absence of mucosal muscle plate, presence or absence of submucosal layer), accidental occurrence (bleeding, perforation, etc.) And the rate of remnants and recurrences after 6 months. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Regarding UEMR, the lumen is first evacuated and then saline is injected. Thereafter, the snare is placed on the lesion and strangled. After confirming that there is no tumor left on the margin, the lesion is resected. After resection, confirm that there are no complications such as bleeding or perforation and no residual lesions. Finally, clipping is performed on the resected part.
|
|
| Interventions/Control_2 | As for CSP, when the lumen is filled with air (carbon dioxide) and the lesion is visually recognized, a snare is placed on the lesion and strangulation is performed. After confirming that there is no tumor left on the margin, resection is performed using a snare wire for CSP without applying power. In principle, clipping after resection is not performed, and if spurting bleeding is recognized, hemostatic closure is performed at the discretion of the attending physician. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients aged 20 years or older who are scheduled to undergo endoscopic treatment for lesions diagnosed as low-grade duodenal tumors of 12 mm or less in our department. If there are multiple lesions, only the largest lesion, which is 12 mm or less, shall be regarded as accurate and assigned. Regarding postoperative complications, if only the same lesion is involved and bleeding or perforation occurs in other lesions of multiple lesions, it is regarded as different. | |||
| Key exclusion criteria | 1) Patients with multiple duodenal tumors associated with Familiar adenomatous polyposis and hereditary non-polyposis colorectal cancer
2) Patients who strongly suspect cancer / high grade adenoma in preoperative examination and biopsy 3) Patients who have undergone surgery for the upper gastrointestinal tract 4) Patients with blood coagulation dysfunction, patients who cannot manage anticoagulant / antiplatelet agents according to the guidelines for medical treatment of gastrointestinal endoscopy 5) Severe organ failure case 6) Cases determined by the attending physician to be inappropriate for registration |
|||
| Target sample size | 130 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keio University, school of medicine | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo | ||||||
| TEL | 0333531211 | ||||||
| motohikokato@keio.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keio University, school of medicine | ||||||
| Division name | Cancer center, division of research and development for minimal invasive treatment | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo | ||||||
| TEL | 0333531211 | ||||||
| Homepage URL | |||||||
| kiguchiyoshiyuki@keio.jp | |||||||
| Sponsor | |
| Institute | Keio University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Keio University, school of medicine |
| Address | 35, Shinanomachi, Shinjyuku-ku, Tokyo, Japan |
| Tel | 0333531211 |
| kiguchiyoshiyuki@keio.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000044419 |